The case for metabolic hypertension: is it time to restructure the hypertension paradigm?
Pool
P E
PE
North County Cardiology Research Laboratory, Encinitas, CA 92024.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D050260:Carbohydrate Metabolism; D003327:Coronary Disease / Q000209:etiology; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications / Q000235:genetics / Q000378:metabolism* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D050356:Lipid Metabolism; D009765:Obesity / Q000150:complications
D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents